• Boracay Hotels
• Cebu Hotels
• Free Articles Submissions

Bali Hotels

Web Related Articles

• FDA OKs New Drug for Advanced Prostate Cancer

A new treatment for advanced prostate cancer that hasn't responded to other treatments has been approved by the FDA....

• Prostate Cancer Drug Zytiga May Extend Life

The newly approved prostate cancer pill Zytiga (abiraterone acetate) may extend life by up to four months among men with spreading cancer who have already been treated with chemotherapy, a study shows....

• Coffee May Cut Risk of Prostate Cancer

Drinking coffee regularly may help lower the risk of advanced prostate cancer, a study shows....

• New Drug May Treat Advanced Melanoma

A new drug that fights tumors throughout the bodies of advanced melanoma patients points the way to powerful new treatments for many kinds of cancer....

• New Type of Prostate Cancer Pill Extends Lives

An experimental pill that works differently than other prostate cancer drugs extended the lives of men with spreading cancer by an average of nearly five months....

• Drug Extends Prostate Cancer Survival

Even when medical or surgical castration fails, a potent drug extends survival by 4 months in patients with metastatic prostate cancer....

• FDA: Prostate Cancer Risk From BPH, Hair Drugs

The prostate drugs Proscar, Avodart, and Jalyn and the hair-loss drug Propecia add to the risk of high-grade prostate cancer....

• FDA: Prostate Cancer Risk From BPH, Hair Drugs

The prostate drugs Proscar, Avodart, and Jalyn and the hair-loss drug Propecia add to the risk of high-grade prostate cancer....

• Drug Combo Extends Life With Advanced Breast Cancer

For the first time, a drug treatment has been shown to extend the lives of women with metastatic breast cancer after Herceptin alone failed....

• FDA OKs Provenge for Prostate Cancer Therapy

The FDA has approved Provenge, Dendreon Corp.'s individualized "vaccine" for the treatment of advanced prostate cancer....

• Drug for Enlarged Prostate May Slow Cancer Growth

Avodart, a drug widely used in the treatment of enlarged prostates, may slow cancer growth in men with very early prostate cancers....

• Avodart May Lower Prostate Cancer Risk

Avodart, a widely prescribed drug used to shrink enlarged prostates, appears to reduce the incidence of prostate cancer in men with an increased risk for the disease....

• Avodart May Lower Prostate Cancer Risk

Avodart, a widely prescribed drug used to shrink enlarged prostates, appears to reduce the incidence of prostate cancer in men with an increased risk for the disease....

• Nexavar May Treat Advanced Breast Cancer

Adding the cancer drug Nexavar to standard chemotherapy significantly extends the time until advanced breast cancer progresses, researchers report....

• New Prostate Treatment Can Help Retain Sexual Function

Cancer is the largest reason for death around the world and prostate cancer is the second leading killer of men in the United States. It is a serious illness experienced usually when men are of a mature age, however men of any age can be diagnosed with the disease. According to current statistics, prostate cancer caused over 200 thousand men in the US to suffer and 28,372 to die in 2006....

• Erbitux Helps Treat Advanced Lung Cancer

Adding the targeted drug Erbitux to standard chemotherapy drugs significantly cuts the risk of death for advanced non-small-cell lung cancer patients -- regardless of what chemotherapy combination is used, a study shows....

• Prostate Cancer Staging Can’t Predict Recurrence

When it comes to localized or non-spreading prostate cancer, staging may not be an important predictor of recurrence after the prostate gland is removed, a study shows....

• Survival Improves for Prostate Cancer

Older men with early prostate cancer are far more likely to survive their disease without surgery or radiation today than they were just a few decades ago, a new study shows....

• Lung Cancer Drug Crizotinib Shows Promise

An experimental drug is showing great promise as a targeted treatment for lung cancer patients with a specific genetic abnormality....

• Shorter Course of Radiation May Treat Prostate Cancer

A shorter, cheaper, and more convenient five-week course of radiation appears to work just as well as the traditional seven-and-one-half week schedule for men with prostate cancer, a study shows....

• FDA: Prostate Cancer Drugs Raise Diabetes, Heart Risk

A class of drugs used to treat advanced prostate cancer raise the risk of diabetes and heart disease, the FDA today warned....

• FDA Approves Prostate Cancer Drug Zytiga

The FDA has approved the Johnson & Johnson pill Zytiga for use in combination with the steroid prednisone to treat a certain type of late-stage prostate cancer in men who have already been treated with chemotherapy....

• FDA Approves Prostate Cancer Drug Zytiga

The FDA has approved the Johnson & Johnson pill Zytiga for use in combination with the steroid prednisone to treat a certain type of late-stage prostate cancer in men who have already been treated with chemotherapy....

• Exercise Cuts Prostate Cancer Death Risk

Men diagnosed with prostate cancer may be able to reduce their risk of death not just from prostate cancer but from any cause by exercising vigorously for at least three hours per week, new research indicates....

• New Test Checks for Prostate Cancer Return

Researchers say they have developed a highly sensitive prostate specific antigen (PSA) test that may identify prostate cancer patients who are likely to relapse after treatment....

• Study: Radioactive Seeds Beat Out Other Prostate Cancer Treatments

For most men with prostate cancer, having radioactive seeds implanted in the prostate is associated with fewer serious side effects than either surgery to remove the prostate or having a beam of high-energy radiation aimed directly at the cancer, researchers say....

• New Doubts on Value of Prostate Cancer Screening

A study from Sweden raises new questions about the value of screening average-risk men for prostate cancer....

• Breast Cancer Drug Eribulin Extends Survival

The new breast cancer drug eribulin (Halaven) extends survival two and a half months longer than other therapies for advanced breast cancer, researchers report....